Randy Polonsky

Chief Financial Officer

Randy Polonsky serves as Biocartis' Chief Financial Officer (CFO) and brings a wealth of experience in financial planning and analysis, corporate development, operational excellence, and leadership across both public and private equity global companies. Most recently, Mr. Polonsky was VP of Financial Planning and Analysis at Talis Biomedical. Prior to Talis, he worked at Vyaire Medical and CDW, where he held progressively senior roles in finance. Mr. Polonsky holds a BBA from the University of Wisconsin and an MBA from DePaul University school of business.

Roger Moody

Chief Executive Officer

More than 30 years of experience in the life science and medical technology market, experienced in scaling up public and private companies.

Randy Polonsky

Chief Financial Officer

Seasoned executive with 15+ years of experience in financial planning and analysis, corporate development, operational excellence, and leadership across both public and private equity global companies.

W. Michael Korn, MD

Chief Medical and Scientific Officer

Dr. Korn is a renowned Molecular and Gastrointestinal Oncologist with extensive experience in the development and implementation of precision oncology strategies.

David Dejans

Chief Commercial Officer

Accomplished leader with almost 20 years of experience in managing commercial organizations in the field of molecular biology and immuno-assays.

Sarah Baudenelle

Chief Manufacturing Officer

Senior operations leader with 15+ years of dedicated experience in operations management. Excels in optimizing processes, streamlining efficiencies, and ensuring seamless operations in diagnostics and pharma.

Susy Spruyt

Chief People Officer

Accomplished leader with 20+ years of experience in human resources and organizational development. Keen ability to foster a culture of growth, innovation, talent management and employee well-being.